NCT00439296 2021-03-17
ABT-751 With Chemotherapy for Relapsed Pediatric ALL
Therapeutic Advances in Childhood Leukemia Consortium
Phase 1/2 Terminated
Clinical Trials
12 trialsNCT00436852 2019-07-17
ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment
Children's Oncology Group
Phase 2 Completed
NCT00047489 2018-10-31
Study of ABT-751 in Patients With Refractory Hematologic Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00735878 2018-10-12
Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer
Dartmouth-Hitchcock Medical Center
Phase 1/2 Terminated
NCT00297089 2013-01-31
A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
AbbVie
Phase 1/2 Completed
NCT00471718 2012-07-11
ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Vanderbilt-Ingram Cancer Center
Phase 1/2 Terminated
NCT00036959 2012-03-15
ABT-751 in Treating Young Patients With Refractory Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00354562 2011-01-07
A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
Abbott
Phase 1/2 Terminated
NCT00063102 2007-11-29
A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.
Abbott
Phase 2 Completed
NCT00073112 2007-11-29
A Study of ABT-751 in Patients With Renal Cell Cancer
Abbott
Phase 2 Completed
NCT00073138 2007-11-29
A Study of ABT-751 in Patients With Colorectal Cancer
Abbott
Phase 2 Completed
NCT00073151 2007-11-29
A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
Abbott
Phase 2 Completed